New automation solutions allow automation of entire workflows in laboratories. In this way, bottlenecks are removed, and equally qualitative and precise results can be achieved much faster, at a lower cost and with greater flexibility.
Interview with Luc Van Laer, Product Manager Analis. Artikel of Joris Hendrickx
Within your activities, what are the most remarkable developments?
" Analis is a distributor of scientific instruments in the Benelux.
We offer great added value by combining the solutions of various suppliers and then bringing that whole package to the market. We have a very extensive range of products, particularly in the field of genomics . This enables us to offer products for each step of the genomics workflow.”
“This is also the field where the biggest (r)evolutions have taken place in recent decades, just think of the new developments in nucleic acid sequencing (next generation sequencing), allowing us to map out certain diseases very quickly. This technology has also proven to be of enormous value for the rapid development of COVID-19-vaccines."
Continue reading the full interview :
What technologies are you using to respond to new and changing needs through COVID-19?
So how exactly does it work?
What is the added value of these technologies for cancer research?
And within the field of synthetic biology?